Axsome Therapeutics Ownership | Who Owns Axsome Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Axsome Therapeutics Ownership Summary


Axsome Therapeutics is owned by 15.25% institutional investors, 15.71% insiders, and 69.04% retail investors. Vanguard group is the largest institutional shareholder, holding 8.33% of AXSM shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.69% of its assets in Axsome Therapeutics shares.

AXSM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAxsome Therapeutics15.25%15.71%69.04%
SectorHealthcare Stocks 232.51%10.72%-143.23%
IndustryBiotech Stocks 384.56%10.58%-295.14%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group4.16M8.33%$760.66M
Blackrock funding, inc. /de3.91M7.82%$714.77M
Blackrock3.30M6.96%$265.65M
Wellington management group llp1.33M2.70%$162.08M
Rtw investments, lp1.12M2.26%$135.89M
Price t rowe associates inc /md/1.04M2.10%$126.00M
Geode capital management1.01M2.02%$184.54M
Invesco990.56K2.00%$120.30M
State street942.96K1.91%$114.52M
Fmr927.88K1.88%$112.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management668.71K59.30%$122.13M
Svb capital management33.85K12.95%$4.11M
Fairmount funds management815.18K8.91%$99.00M
Tri locum partners lp292.14K8.16%$35.48M
Iridian asset management llc/ct73.78K4.96%$13.48M
Pfm health sciences, lp530.33K4.95%$64.41M
Nationale-nederlanden powszechne towarzystwo emerytalne278.83K4.52%$50.93M
Ghost tree capital150.00K3.78%$12.07M
Deep track capital, lp900.00K3.05%$109.31M
First turn management152.61K2.78%$18.53M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp1.33M0.03%609.52K
Norges bank495.46K0.01%495.46K
Price t rowe associates inc /md/1.04M0.01%424.70K
Invesco990.56K0.02%419.01K
Marshall wace, llp378.02K0.05%321.31K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il486.76K2.40%-1.20M
Macquarie group---1.08M
Ra capital management---1.00M
Rtw investments, lp1.12M1.67%-398.02K
1832 asset management---363.20K

New Positions

HolderShares% AssetsChangeValue
Norges bank495.46K0.01%495.46K$90.49M
Vestal point capital, lp150.00K0.82%150.00K$18.22M
M&g90.33K0.08%90.33K$16.53M
Summit financial77.54K0.14%77.54K$9.42M
Scout investments69.56K0.15%69.56K$5.60M

Sold Out

HolderChange
Financial gravity asset management-1.00
Atlantic union bankshares-1.00
Geowealth management-5.00
Ghp investment advisors-6.00
Montag a & associates-8.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025127-66.49%7,628,642-79.48%150.27%58-71.14%38-60.42%
Sep 30, 2025146-59.22%7,876,625-78.56%150.29%77-62.44%34-60.47%
Jun 30, 2025365-3.18%37,827,2692.24%761.33%2069.57%89-25.21%
Mar 31, 202519-94.14%7,027,292-81.11%140.24%8-94.97%9-90.00%
Dec 31, 20243193.57%37,149,265-2.97%771.22%15315.04%90-1.10%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.31M2.69%114.89K
Vanguard Total Stock Mkt Idx Inv1.24M2.48%-25.86K
iShares Russell 2000 ETF973.92K1.95%-
Vanguard Small Cap Index955.65K1.92%-7.08K
Macquarie Small Cap Core I651.89K1.31%-48.97K
Delaware Small Cap Core I579.64K1.21%-3.59K
Vanguard Small Cap Growth Index Inv539.73K1.08%-181.00
Bellevue Healthcare Ord506.57K1.06%506.57K
Vanguard Institutional Extnd Mkt Idx Tr444.16K0.89%-196.42K
Fidelity Small Cap Index405.99K0.81%32.79K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 02, 2026TABUTEAU HERRIOT Chief Executive OfficerSell$6.02M
Jan 22, 2026Pizzie Nick Chief Financial OfficerSell$2.26M
Jan 21, 2026Maizel Ari Chief Commercial OfficerSell$1.38M
Jan 07, 2026TABUTEAU HERRIOT Chief Executive OfficerSell$5.33M
Jan 06, 2026TABUTEAU HERRIOT Chief Executive OfficerSell$5.08M

Insider Transactions Trends


DateBuySell
2026 Q1-6
2025 Q4-10
2025 Q3313
2025 Q2-11
2025 Q1-2

AXSM Ownership FAQ


Who Owns Axsome Therapeutics?

Axsome Therapeutics shareholders are primarily institutional investors at 15.25%, followed by 15.71% insiders and 69.04% retail investors. The average institutional ownership in Axsome Therapeutics's industry, Biotech Stocks , is 384.56%, which Axsome Therapeutics falls below.

Who owns the most shares of Axsome Therapeutics?

Axsome Therapeutics’s largest shareholders are Vanguard group (4.16M shares, 8.33%), Blackrock funding, inc. /de (3.91M shares, 7.82%), and Blackrock (3.3M shares, 6.96%). Together, they hold 23.11% of Axsome Therapeutics’s total shares outstanding.

Does Blackrock own Axsome Therapeutics?

Yes, BlackRock owns 6.96% of Axsome Therapeutics, totaling 3.3M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 265.65M$. In the last quarter, BlackRock increased its holdings by 104.5K shares, a 3.27% change.

Who is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested, with 59.30% of its assets in 668.71K Axsome Therapeutics shares, valued at 122.13M$.

Who is the top mutual fund holder of Axsome Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Axsome Therapeutics shares, with 2.69% of its total shares outstanding invested in 1.31M Axsome Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools